Afya (AFYA)
(Delayed Data from NSDQ)
$14.50 USD
+0.24 (1.68%)
Updated Aug 5, 2025 04:00 PM ET
After-Market: $14.49 -0.01 (-0.07%) 7:58 PM ET
1-Strong Buy of 5 1
A Value B Growth F Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
AFYA 14.50 +0.24(1.68%)
Will AFYA be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for AFYA based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AFYA
Best Growth Stocks to Buy for August 4th
Perdoceo Education (PRDO) Surpasses Q2 Earnings and Revenue Estimates
AFYA: What are Zacks experts saying now?
Zacks Private Portfolio Services
Best Growth Stocks to Buy for July 31st
Best Growth Stocks to Buy for July 29th
AFYA vs. LOPE: Which Stock Should Value Investors Buy Now?
Other News for AFYA
Afya (AFYA) Receives Upgrade from Morgan Stanley with Adjusted Price Target
Afya just upgraded at Morgan Stanley, here's why
This Sarepta Therapeutics Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
Afya just upgraded at Citi, here's why
Afya (AFYA) Receives Rating Upgrade from Citigroup | AFYA Stock News